Results 271 to 280 of about 12,265,574 (365)
Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi +10 more
wiley +1 more source
Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study. [PDF]
Costes-Albrespic M +13 more
europepmc +1 more source
Assessment of antihypertensive treatment prescription in the elderly.
Julie Martinoni
openalex +1 more source
Abstract Aims The impact of steatotic liver disease (SLD) subtypes on incident type 2 diabetes remains unclear. We investigated the association of metabolic dysfunction‐associated steatotic liver disease (MASLD), MetALD (MASLD with moderate alcohol consumption), and alcohol‐related liver disease (ALD) with incident type 2 diabetes in Korean adults aged
Goh Eun Chung +6 more
wiley +1 more source
Abstract Introduction Diabetic kidney disease (DKD) and diabetic nephropathy (DN) affect around 40% of diabetic patients but lack accurate risk prediction tools that include social determinants and demographic complexity. We developed and validated an ensemble machine learning model for three‐year DKD/DN risk prediction with deployment readiness ...
Ayla M. Tourkmani +5 more
wiley +1 more source
Modulation of the QT interval duration in hypertension with antihypertensive treatment
J. Klimas, P. Kruzliak, S. Rabkin
semanticscholar +1 more source
Azilsartan as an antihypertensive treatment in Japanese children under 6 years old: A phase 3 open-label long-term study. [PDF]
Ito S +4 more
europepmc +1 more source
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee +15 more
wiley +1 more source

